This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Oct 13;33(42):5492.

doi: 10.1016/j.vaccine.2015.05.020. Epub 2015 Jun 25.

bioCSL Limited's 2009 clinical trial to assess the immunogenicity and safety of trivalent influenza vaccine in US children raises concern

Paul V Effler¹, Heath A Kelly²

Affiliations

Affiliations

¹ School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Western Australia, Australia. Electronic address: pauleffler@gmail.com.
² National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.

PMID: 26119986
DOI: 10.1016/j.vaccine.2015.05.020

Comment

bioCSL Limited's 2009 clinical trial to assess the immunogenicity and safety of trivalent influenza vaccine in US children raises concern

Paul V Effler et al. Vaccine. 2015.

. 2015 Oct 13;33(42):5492.

doi: 10.1016/j.vaccine.2015.05.020. Epub 2015 Jun 25.

Authors

Paul V Effler¹, Heath A Kelly²

Affiliations

¹ School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Western Australia, Australia. Electronic address: pauleffler@gmail.com.
² National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.

PMID: 26119986
DOI: 10.1016/j.vaccine.2015.05.020

No abstract available

PubMed Disclaimer

Comment in

Reply to Letter to the Editor.
Hu W, Sawlwin DC. Hu W, et al. Vaccine. 2015 Oct 13;33(42):5493. doi: 10.1016/j.vaccine.2015.05.019. Epub 2015 Jun 25. Vaccine. 2015. PMID: 26117149 No abstract available.

Comment on

Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.
Brady RC, Hu W, Houchin VG, Eder FS, Jackson KC, Hartel GF, Sawlwin DC, Albano FR, Greenberg M. Brady RC, et al. Vaccine. 2014 Dec 12;32(52):7141-7. doi: 10.1016/j.vaccine.2014.10.024. Epub 2014 Oct 29. Vaccine. 2014. PMID: 25454878 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information